More for Palantir, less for mRNA, and a disaster database redemption arc

In this episode of The Indicator from Planet Money, the hosts discuss three different indicators of the week. The first indicator is Palantir's $1 billion in sales, driven by government contracts, particularly those related to immigration enforcement, leading to a high company valuation. The second indicator is the Health Department's $500 million cut from mRNA vaccine research, a decision based on the claim that mRNA vaccines are ineffective against upper respiratory infections, despite evidence to the contrary. The third indicator is the revival of the billion-dollar weather and climate disasters database by the non-profit Climate Central, which hired the database's original architect after it was retired by NOAA.